Change set

Pick exam & year, then Go.

Question map
Not attempted Correct Incorrect ★ Bookmarked
Loading…
Q55 (UPPCS/2024) Science & Technology › Biotechnology & Health

What is R21/Matrix-M™?

Result
Your answer: —  ·  Correct: A

Explanation

R21/Matrix-M™ is the second malaria vaccine recommended by the World Health Organization (WHO) for the prevention of malaria in children. It was developed by the University of Oxford and is manufactured by the Serum Institute of India (SII). The vaccine utilizes Novavax's Matrix-M™ adjuvant to enhance the immune response. In October 2023, the WHO recommended its use, noting its high efficacy and cost-effectiveness. The Serum Institute of India has established a massive production capacity for this vaccine, which is expected to significantly bridge the gap between supply and demand in malaria-endemic regions, particularly in Africa. Unlike the RTS,S vaccine, R21 is easier to manufacture at scale. Options B, C, and D are incorrect as Bharat Biotech is not the manufacturer of this vaccine, and it is designed to combat malaria, not AIDS.

How others answered
Each bar shows the % of students who chose that option. Green bar = correct answer, blue outline = your choice.
Community Performance
Out of everyone who attempted this question.
0%
got it right
✓ Thank you! We'll review this.

SIMILAR QUESTIONS

IAS · 2010 · Q20 Relevance score: 1.67

Widespread resistance of malarial parasite to drugs like chloroquine has prompted attempts to develop a malarial vaccine to combat malaria. Why is it difficult to develop an effective malaria vaccine ?

CDS-I · 2007 · Q56 Relevance score: -0.59

Vaccination is available against all of the following diseases except

CDS-II · 2020 · Q56 Relevance score: -0.96

Which one of the following Indian institutes was approved by the Drugs Controller General of India for conducting human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate?

IAS · 2022 · Q69 Relevance score: -1.35

In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements : 1. The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform. 2. Sputnik V vaccine is manufactured using vector based platform. 3. COVAXIN is an inactivated pathogen based vaccine. Which of the statements given above are correct ?

NDA-II · 2009 · Q58 Relevance score: -2.51

The Haffkine Institute, Mumbai, is known for its work on the production of